Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancer.
Journal: The oncologist
Published: April 29, 2025
Dostarlimab and niraparib in primary advanced ovarian cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 11, 2025
Drp1 splice variants regulate ovarian cancer mitochondrial dynamics and tumor progression.
Journal: EMBO reports
Published: February 26, 2024
GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15.
Journal: bioRxiv : the preprint server for biology
Published: February 14, 2024
GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15.
Journal: Gynecologic oncology
Published: October 27, 2023
Alternative splice variants of the mitochondrial fission protein DNM1L/Drp1 regulate mitochondrial dynamics and tumor progression in ovarian cancer.
Journal: bioRxiv : the preprint server for biology
Published: October 04, 2023
Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer.
Journal: Cell communication and signaling : CCS
Published: September 14, 2023
Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signaling.
Journal: bioRxiv : the preprint server for biology
Published: September 11, 2023
Extracellular Glutathione Peroxidase GPx3 and Its Role in Cancer.
Journal: Cancers
Published: June 29, 2020
Last Updated: 09/26/2026